4
Changes in Ownership
Xeris Biopharma Holdings, Inc. Filed Acc 0001635065-26-000002
Director sold 16,000 shares at $6.09 ($97,507)
- Director acquired 24,193 shares (grant or award)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
BORMANN-KENNEDY BARBARA-JEAN ANNE · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-06-04 | Sale : show line 1 in the form 10b5-1 | −16,000 | $6.09 | $97,507 | 126,500 | D |
| 2026-06-04 | Grant or award : show line 2 in the form 10b5-1 | +24,193 | 150,693 | D | ||
| Open-market sales · 16,000 sh · avg $6.09 · $97,507 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-06-04 | Grant or award : show line 3 in the form 10b5-1 Stock Option (Right to Buy) | +32,996 | $6.15 | $202,925 | 32,996 | D |
Loading xslF345X06/wk-form4_1780697885.xml…